2015
DOI: 10.1242/dev.120824
|View full text |Cite
|
Sign up to set email alerts
|

Protein phosphatase 2A promotes the transition to G0 during terminal differentiation in Drosophila

Abstract: Protein phosphatase type 2A complex (PP2A) has been known as a tumor suppressor for over two decades, but it remains unclear exactly how it suppresses tumor growth. Here, we provide data indicating a novel role for PP2A in promoting the transition to quiescence upon terminal differentiation in vivo. Using Drosophila eyes and wings as a model, we find that compromising PP2A activity during the final cell cycle prior to a developmentally controlled cell cycle exit leads to extra cell divisions and delays entry i… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
19
0

Year Published

2016
2016
2021
2021

Publication Types

Select...
7
2

Relationship

2
7

Authors

Journals

citations
Cited by 19 publications
(21 citation statements)
references
References 79 publications
2
19
0
Order By: Relevance
“…These in vivo findings, together with numerous biochemical studies showing that PP2A can dephosphorylate Akt (Perrotti & Neviani, 2013;Seshacharyulu et al, 2013), indicate that a [Ca 2+ ]i-regulated PP2A isoform(s) likely acts downstream of TRPV6/Trpv6 and regulates the quiescent state in epithelial cells. This is in good agreement with a recent study in Drosophila showing that compromising PP2A activity delays cell cycle exit (Sun & Buttitta, 2015). The TRPV6-[Ca 2+ ]i-PP2A-Akt signaling axis appears to be conserved in human colon cells because inhibition of TRPV6, [Ca 2+ ]i and PP2A all increased LoVo cell proliferation.…”
Section: Discussionsupporting
confidence: 91%
See 1 more Smart Citation
“…These in vivo findings, together with numerous biochemical studies showing that PP2A can dephosphorylate Akt (Perrotti & Neviani, 2013;Seshacharyulu et al, 2013), indicate that a [Ca 2+ ]i-regulated PP2A isoform(s) likely acts downstream of TRPV6/Trpv6 and regulates the quiescent state in epithelial cells. This is in good agreement with a recent study in Drosophila showing that compromising PP2A activity delays cell cycle exit (Sun & Buttitta, 2015). The TRPV6-[Ca 2+ ]i-PP2A-Akt signaling axis appears to be conserved in human colon cells because inhibition of TRPV6, [Ca 2+ ]i and PP2A all increased LoVo cell proliferation.…”
Section: Discussionsupporting
confidence: 91%
“…While non-proliferative, these cells retain the ability to re-enter the cell cycle in response to appropriate cell-intrinsic and extrinsic signals (Matson & Cook, 2017;Sun & Buttitta, 2015;Yao, 2014). Quiescence protects long-lived cells, such as adult stem cells against the accumulation of genomic aberrations and stress.…”
Section: Introductionmentioning
confidence: 99%
“…Prolonging the final G2/M effectively delayed cell cycle exit with timing similar to that observed when we compromise NuA4 function (up to 30 hr APF, Figure 7, A and B), while prolonging the final cell cycle with an RNAi to e2f1 or the expression of a dominantly active Rbf, Rbf 280 , did not perturb the overall timing of cell cycle exit ( Figure S7, A-D). Other genetic conditions known to prolong the cell cycle such as generating Minute +/2 clones or slowly dividing Dp null mutant clones also did not detectibly delay cell cycle exit in the pupal wing (Martin and Morata 2006;Sun and Buttitta 2015). This demonstrates that simply slowing cell cycles during the proliferative phases or slowing the final G1/S does not delay cell cycle exit in the wing.…”
Section: Nua4 Inhibition Does Not Delay Cell Cycle Exit Through the Pmentioning
confidence: 88%
“…Western blots were performed using BioRad TGX precast 4-20% gels, and HRP conjugated secondary antibodies with high sensitivity ECL detection reagents (Thermo) as described (Sun and Buttitta, 2015). We used the following antibodies: anti-Tyr15-P-cdc2 (1:1000, Cell Signaling Technologies, #9111), anti-EcR common (1:1000, DSHB, DDA2.7), anti-Wee (1:700, kindly provided by Dr S. Campbell), anti-Broad Z1 and Broad-Core (1:100, DSHB, #Z1.3C11.OA1 and #25E9.D7), mouse anti-Ī±-tubulin (1:1000, DSHB, AA4.3) and anti-total cdc2 (1:1000, Millipore, #06-923).…”
Section: Methodsmentioning
confidence: 99%